VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Capital expenditures, 2025
- $438M
- YoY, 2025
- +47.0%
- 5-year CAGR
- +11.0%
- 10-year CAGR
- +25.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $438M | +47.0% |
| 2024 | $298M | +48.6% |
| 2023 | $200M | −2.1% |
| 2022 | $205M | −12.9% |
| 2021 | $235M | −9.5% |
| 2020 | $260M | +244.6% |
| 2019 | $75M | −21.0% |
| 2018 | $95M | −4.0% |
| 2017 | $99M | +75.8% |
| 2016 | $57M | +24.9% |
| 2015 | $45M | −11.5% |
| 2014 | $51M | −0.4% |
| 2013 | $51M | −27.8% |
| 2012 | $71M | +105.6% |
| 2011 | $35M | −9.1% |
| 2010 | $38M | +62.0% |
| 2009 | $23M | −27.0% |
| 2008 | $32M | — |